Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TUMOR SUPPRESSION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 344 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Macoska, JA; Xu, JL; Ziemnicka, D; Schwab, TS; Rubin, MA; Kotula, L
      Loss of expression of human spectrin src homology domain binding protein 1is associated with 10p loss in human prostatic adenocarcinoma

      NEOPLASIA
    2. Roper, E; Weinberg, W; Watt, FM; Land, H
      P19(ARF)-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes

      EMBO REPORTS
    3. Peeper, DS; Dannenberg, JH; Douma, S; Riele, HT; Bernards, R
      Escape from premature senescence is not sufficient for oncogenic transformation by Ras

      NATURE CELL BIOLOGY
    4. Berx, G; Van Roy, F
      The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

      BREAST CANCER RESEARCH
    5. Viswanathan, M; Tsuchida, N; Shanmugam, G
      Selective deletion of p14(ARF) exon 1 beta of the INK4a locus in oral squamous cell carcinomas of Indians

      ORAL ONCOLOGY
    6. Leone, G; Sears, R; Huang, E; Rempel, R; Nuckolls, F; Park, CH; Giangrande, P; Wu, LZ; Saavedra, HI; Field, SJ; Thompson, MA; Yang, HD; Fujiwara, Y; Greenberg, ME; Orkin, S; Smith, C; Nevins, JR
      Myc requires distinct E2F activities to induce S phase and apoptosis

      MOLECULAR CELL
    7. Matsuzawa, S; Reed, JC
      Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses

      MOLECULAR CELL
    8. Liu, J; Stevens, J; Rote, CA; Yost, HJ; Hu, YX; Neufeld, KL; White, RL; Matsunami, N
      Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein

      MOLECULAR CELL
    9. Shapiro, GI; Supko, JG; Patterson, A; Lynch, C; Lucca, J; Zacarola, PF; Muzikansky, A; Wright, JJ; Lynch, TJ; Rollins, BJ
      A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    10. Ding, ZH; Parchment, RE; LoRusso, PM; Zhou, JY; Li, J; Lawrence, TS; Sun, Y; Wu, GS
      The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways

      CLINICAL CANCER RESEARCH
    11. Peters, MA; Ostrander, EA
      Prostate cancer: simplicity to complexity

      NATURE GENETICS
    12. O'Reilly, MA
      DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking tofacilitate repair

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    13. Kishimoto, H; Urade, M; Hashimoto-Tamaoki, T; Furuyama, J
      Overexpression of SCC antigen and cyclins in an adenoid squamous carcinomacell line derived from the maxillary sinus

      INTERNATIONAL JOURNAL OF ONCOLOGY
    14. Hu, JC; Lei, Y; Hong, X; Lu, ZG; Zhai, ZH
      Rapid senescence induced by overexpression of p53 in NIH3T3 cells

      CHINESE SCIENCE BULLETIN
    15. Hann, B; Balmain, A
      Building 'validated' mouse models of human cancer

      CURRENT OPINION IN CELL BIOLOGY
    16. Pearson, M; Pelicci, PG
      PML interaction with p53 and its role in apoptosis and replicative senescence

      ONCOGENE
    17. Koul, D; Parthasarathy, R; Shen, RJ; Davies, MA; Jasser, SA; Chintala, SK; Rao, JS; Sun, Y; Benvenisite, EN; Liu, TJ; Yung, WKA
      Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN

      ONCOGENE
    18. Rizos, H; Puig, S; Badenas, C; Malvehy, J; Darmanian, AP; Jimenez, L; Mila, M; Kefford, RF
      A melanoma-associated germline mutation in exon 1 beta inactivates p14ARF

      ONCOGENE
    19. Mende, I; Malstrom, S; Tsichlis, PN; Vogt, PK; Aoki, M
      Oncogenic transformation induced by membrane-targeted Akt2 and Akt3

      ONCOGENE
    20. Yang, HY; Shao, RP; Hung, MC; Lee, MH
      p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis

      ONCOGENE
    21. Brooks, DG; James, RM; Patek, CE; Williamson, J; Arends, MJ
      Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF)

      ONCOGENE
    22. Yam, JWP; Chan, KW; Hsiao, WLW
      Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B

      ONCOGENE
    23. Ahmed, CMI; Johnson, DE; Demers, GW; Engler, H; Howe, JA; Wills, KN; Wen, SF; Shinoda, J; Beltran, J; Nodelman, M; Machemer, T; Maneval, DC; Nagabhushan, TL; Sugarman, BJ
      Interferon alpha 2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers

      CANCER GENE THERAPY
    24. Bogdan, S; Senkel, S; Esser, F; Ryffel, GU; von Strandmann, EP
      Misexpression of Xsiah-2 induces a small eye phenotype in Xenopus

      MECHANISMS OF DEVELOPMENT
    25. Newman, L; Xia, WY; Yang, HY; Sahin, A; Bondy, M; Lukmanji, F; Hung, MC; Lee, MH
      Correlation of p27 protein expression with HER-2/neu expression in breast cancer

      MOLECULAR CARCINOGENESIS
    26. Inoue, K; Zindy, F; Randle, DH; Rehg, JE; Sherr, CJ
      Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

      GENES & DEVELOPMENT
    27. Martins, RP; Leach, RE; Krawetz, SA
      Whole-body gene expression by data mining

      GENOMICS
    28. Campisi, J
      From cells to organisms: can we learn about aging from cells in culture?

      EXPERIMENTAL GERONTOLOGY
    29. Campisi, J; Kim, SH; Lim, CS; Rubio, M
      Cellular senescence, cancer and aging: the telomere connection

      EXPERIMENTAL GERONTOLOGY
    30. Yam, D; Peled, A; Shinitzky, M
      Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    31. Hojo, T; Akiyama, Y; Nagasaki, K; Maruyama, K; Kikuchi, K; Ikeda, T; Kitajima, M; Yamaguchi, K
      Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues

      CANCER LETTERS
    32. Liu, Q; El-Deiry, WS; Gazitt, Y
      Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines

      EXPERIMENTAL HEMATOLOGY
    33. Koumenis, C; Alarcon, R; Hammond, E; Sutphin, P; Hoffman, W; Murphy, M; Derr, J; Taya, Y; Lowe, SW; Kastan, M; Giaccia, A
      Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation

      MOLECULAR AND CELLULAR BIOLOGY
    34. Eischen, CM; Woo, D; Roussel, MF; Cleveland, JL
      Apoptosis triggered by Myc-induced suppression of Bcl-X-L or Bcl-2 is bypassed during lymphomagenesis

      MOLECULAR AND CELLULAR BIOLOGY
    35. Zhang, SL; DuBois, W; Ramsay, ES; Bliskovski, V; Morse, HC; Taddesse-Heath, L; Vass, WC; DePinho, RA; Mock, BA
      Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility

      MOLECULAR AND CELLULAR BIOLOGY
    36. Zhan, QM; Zhao, SC; Xu, Z
      Antitumor activity of cytotropic heterogeneous molecular lipids (CHML) on human breast cancer xenograft in nude mice

      ANTICANCER RESEARCH
    37. Hildebrandt, T; Van Dijk, MCRF; Van Muijen, GNP; Weidle, UH
      Loss of heterozygosity of gene THW is frequently found in melanoma metastases

      ANTICANCER RESEARCH
    38. Kapranos, N; Stathopoulos, GP; Manolopoulos, L; Kokka, E; Papadimitriou, C; Bibas, A; Yiotakis, J; Adamopoulos, G
      p53, p21 and p27 protein expression in head and neck cancer and their prognostic value

      ANTICANCER RESEARCH
    39. Ho, GH; Calvano, JE; Bisogna, M; Abouezzi, Z; Borgen, PI; Cordon-Cardo, C; Van Zee, KJ
      Genetic alterations of the p14(ARF)-hdm2-p53 regulatory pathway in breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    40. Holland, EC
      Animal models of cell cycle dysregulation and the pathogenesis of gliomas

      JOURNAL OF NEURO-ONCOLOGY
    41. Kokunai, T; Urui, S; Tomita, H; Tamaki, N
      Overcoming of radioresistance in human gliomas by p21(WAF1/CIP1) antisenseoligonucleotide

      JOURNAL OF NEURO-ONCOLOGY
    42. Eklund, LK; Islam, K; Soderkvist, P; Islam, MQ
      Regional mapping of suppressor loci for anchorage independence and tumorigenicity on human chromosome 9

      CANCER GENETICS AND CYTOGENETICS
    43. Sherr, CJ
      Parsing Ink4a/Arf: "Pure" p16-null mice

      CELL
    44. Huang, LW; Chou, YY; Chao, SL; Chen, TJ; Lee, TTY
      p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: Overexpression of p53 predicts poor disease outcome

      GYNECOLOGIC ONCOLOGY
    45. Zafonte, BT; Amanatullah, DF; Sage, D; Augenlicht, LH; Pestell, RG
      Ras regulation of cyclin-dependent immunoprecipitation kinase assays

      REGULATORS AND EFFECTORS OF SMALL GTPASES, PT G
    46. Palmero, I; Serrano, M
      Induction of senescence by oncogenic Ras

      REGULATORS AND EFFECTORS OF SMALL GTPASES, PT G
    47. Chakravarthy, MV; Fiorotto, ML; Schwartz, RJ; Booth, FW
      Long-term insulin-like growth factor-I expression in skeletal muscles attenuates the enhanced in vitro proliferation ability of the resident satellite cells in transgenic mice

      MECHANISMS OF AGEING AND DEVELOPMENT
    48. Li, X; Hui, AM; Shi, YZ; Takayama, T; Makuuchi, M
      Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder

      HUMAN PATHOLOGY
    49. Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A
      Loss of p16(Ink4a) confers susceptibility to metastatic melanoma in mice

      NATURE
    50. Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA
      Loss of p16(Ink4a) with retention of p19(Arf) predisposes mice to tumorigenesis

      NATURE
    51. Ruland, J; Sirard, C; Elia, A; MacPherson, D; Wakeham, A; Li, LM; de la Pompa, JL; Cohen, SN; Mak, TW
      p53 Accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    52. Sotillo, R; Garcia, JF; Ortega, S; Martin, J; Dubus, P; Barbacid, M; Malumbres, M
      Invasive melanoma in Cdk4-targeted mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    53. Testa, JR; Bellacosa, A
      Commentary - AKT plays a central role in tumorigenesis

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    54. Hormigo, A; Friedlander, DR; Brittis, PA; Zagzag, D; Grumet, M
      Reduced tumorigenicity of rat glioma cells in the brain when mediated by hygromycin phosphotransferase

      JOURNAL OF NEUROSURGERY
    55. Huh, NE; Pasumarthi, KBS; Soonpaa, MH; Jing, S; Patton, B; Field, LJ
      Functional abrogation of p53 is required for T-Ag induced proliferation incardiomyocytes

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    56. Gohring, UJ; Bersch, A; Becker, M; Neuhaus, W; Schondorf, T
      P21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer

      JOURNAL OF CLINICAL PATHOLOGY
    57. Muraoka, RS; Lenferink, AEG; Simpson, J; Brantley, DM; Roebuck, LR; Yakes, FM; Arteaga, CL
      Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function

      JOURNAL OF CELL BIOLOGY
    58. Neville, PJ; Thomas, N; Campbell, IG
      Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors

      INTERNATIONAL JOURNAL OF CANCER
    59. White, MK; Baireddy, V; Strayer, DS
      Natural protection from apoptosis by surfactant protein A in type II pneumocytes

      EXPERIMENTAL CELL RESEARCH
    60. Dubey, P; Wu, H; Reiter, RE; Witte, ON
      Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression

      CANCER RESEARCH
    61. Nikitin, AY; Shan, B; Flesken-Nikitin, A; Chang, KH; Lee, WH
      The retinoblastoma gene regulates somatic growth during mouse development

      CANCER RESEARCH
    62. Yang, CT; You, L; Uematsu, K; Yeh, CC; McCormick, F; Jablons, DM
      p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53

      CANCER RESEARCH
    63. Yang, WC; Velcich, A; Mariadason, J; Nicholas, C; Corner, G; Houston, M; Edelmann, W; Kucherlapati, R; Holt, PR; Augenlicht, LH
      p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo

      CANCER RESEARCH
    64. Noda, H; Maehara, Y; Irie, K; Kakeji, Y; Yonemura, T; Sugimachi, K
      Growth pattern and expressions of cell cycle regulator proteins p53 and p21 WAF1/CIP1 in early gastric carcinoma

      CANCER
    65. Lewis, JL; Chinswangwatanakul, W; Zheng, B; Marley, SB; Nguyen, DX; Cross, NCP; Banerji, L; Glassford, J; Thomas, NSB; Goldman, JM; Lam, EWF; Gordon, MY
      The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells

      BLOOD
    66. Wang, TJ; Huang, MS; Hong, CY; Tse, V; Silverberg, GD; Hsiao, M
      Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    67. Takahashi, K; Tanaka, S; Ichikawa, A
      Effect of cimetidine on intratumoral cytokine expression in an experimental tumor

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    68. Niida, Y; Stemmer-Rachamimov, AO; Logrip, M; Tapon, D; Perez, R; Kwiatkowski, DJ; Sims, K; MacCollin, M; Louis, DN; Ramesh, V
      Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomassuggests different genetic mechanisms for pathogenesis of TSC lesions

      AMERICAN JOURNAL OF HUMAN GENETICS
    69. DeWolf, WC; Gaston, SM
      The role of cell cycle regulators in cancer: An overview for urologists

      AKTUELLE UROLOGIE
    70. Wiesmuller, L
      The tumor suppressor p53 in the center of a strategy aiming at the alleviation of side effects in cancer therapies

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    71. Malumbres, M; Ortega, S; Barbacid, M
      Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors

      BIOLOGICAL CHEMISTRY
    72. Artandi, SE; DePinho, RA
      Mice without telomerase: what can they teach us about human cancer?

      NATURE MEDICINE
    73. McGarvey, TW; Malkowicz, SB
      Steady state expression of cell-cycle regulatory genes in prostate carcinoma cell lines

      UROLOGIC ONCOLOGY
    74. Ueno, NT; Bartholomeusz, C; Herrmann, JL; Estrov, Z; Shao, RP; Andreeff, M; Price, J; Paul, RW; Anklesaria, P; Yu, DH; Hung, MC
      E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway

      CLINICAL CANCER RESEARCH
    75. Satyamoorthy, K; Chehab, NH; Waterman, MJF; Lien, MC; El-Deiry, WS; Herlyn, M; Halazonetis, TD
      Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells

      CELL GROWTH & DIFFERENTIATION
    76. Gupta, S
      Hepatic polyploidy and liver growth control

      SEMINARS IN CANCER BIOLOGY
    77. Tanaka, N; Taniguchi, T
      The interferon regulatory factors and oncogenesis

      SEMINARS IN CANCER BIOLOGY
    78. Plate, JMD; Harris, JE
      Immune cell functions in pancreatic cancer

      CRITICAL REVIEWS IN IMMUNOLOGY
    79. Artandi, SE; DePinho, RA
      A critical role for telomeres in suppressing and facilitating carcinogenesis

      CURRENT OPINION IN GENETICS & DEVELOPMENT
    80. Scharnhorst, V; Menke, AL; Attema, J; Haneveld, JK; Riteco, N; van Steenbrugge, GJ; van der Eb, AJ; Jochemsen, AG
      EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1gene products on tumorigenicity

      ONCOGENE
    81. Germani, A; Bruzzoni-Giovanelli, H; Fellous, A; Gisselbrecht, S; Varin-Blank, N; Calvo, F
      SIAH-1 interacts with alpha-tubulin and degrades the kinesin Kid by the proteasome pathway during mitosis

      ONCOGENE
    82. Krutovskikh, VA; Troyanovsky, SM; Piccoli, C; Tsuda, H; Asamoto, M; Yamasaki, H
      Differential effect of subcellular localization of communication impairinggap junction protein connexin43 on tumor cell growth in vivo

      ONCOGENE
    83. Nakano, K; Balint, E; Ashcroft, M; Vousden, KH
      A ribonucleotide reductase gene is a transcriptional target of p53 and p73

      ONCOGENE
    84. Nikolopoulos, SN; Spengler, BA; Kisselbach, K; Evans, AE; Biedler, JL; Ross, RA
      The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells

      ONCOGENE
    85. Boulay, JL; Perruchoud, AP; Reuter, J; Bolliger, C; Herrmann, R; Rochlitz, C
      P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients

      CANCER GENE THERAPY
    86. Athanasiou, M; LeGallic, L; Watson, DK; Blair, DG; Mavrothalassitis, G
      Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids

      CANCER GENE THERAPY
    87. Dickopp, A; Esche, H; Swart, G; Seeber, S; Kirch, HC; Opalka, B
      Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells

      CANCER GENE THERAPY
    88. Jang, TJ; Kang, MS; Kim, H; Kim, DH; Lee, JI; Kim, JR
      Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) chemically induced rat mammary carcinogenesis

      JAPANESE JOURNAL OF CANCER RESEARCH
    89. Moshinsky, DJ; Wogan, GN
      UV-induced mutagenesis of human p53: Analysis using a double-selection method in yeast

      ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
    90. Toulouse, A; Loubeau, M; Morin, J; Pappas, JJ; Wu, JP; Bradley, WEC
      RAR beta involvement in enhancement of lung tumor cell immunogenicity revealed by array analysis

      FASEB JOURNAL
    91. Weber, JD; Jeffers, JR; Rehg, JE; Randle, DH; Lozano, G; Roussel, MF; Sherr, CJ; Zambetti, GP
      p53-independent functions of the p19(ARF) tumor suppressor

      GENES & DEVELOPMENT
    92. Inoue, K; Wen, RR; Rehg, JE; Adachi, M; Cleveland, JL; Roussel, MF; Sherr, CJ
      Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis

      GENES & DEVELOPMENT
    93. Young, J; Smith, JR
      Epigenetic aspects of cellular senescence

      EXPERIMENTAL GERONTOLOGY
    94. Desdouets, C; Brechot, C
      p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer

      PATHOLOGIE BIOLOGIE
    95. Quaroni, A; Tian, JQ; Seth, P; Rhys, CA
      p27(Kip1) is an inducer of intestinal epithelial cell differentiation

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    96. Fan, GC; Wu, CT
      Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance

      CANCER LETTERS
    97. Shao, ZM; Radziszewski, WJ; Barsky, SH
      Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms

      CANCER LETTERS
    98. Li, X; Hui, AM; Takayama, T; Cui, X; Shi, Y; Makuuchi, M
      Altered p21(WAF1/CIP1) expression is associated with poor prognosis in extrahepatic bile duct carcinoma

      CANCER LETTERS
    99. Zhang, BN; Watanabe, S; Kohyama, M; Saijo, K; Kusakabe, M; Ohno, T
      Tumor formation suppressed in gamma delta T knock-out mice

      CANCER LETTERS
    100. Thullberg, M; Welcker, M; Bartkova, J; Kjerulff, AA; Lukas, J; Hogberg, J; Bartek, J
      Monoclonal antibody probes for p21(WAF1/CIP1) and the INK4 family of cyclin-dependent kinase inhibitors

      HYBRIDOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 20:33:26